Lantern Pharma Inc. (LTRN) Financial Statements (2026 and earlier)

Company Profile

Business Address 1920 MCKINNEY AVENUE
DALLAS, TX 75201
State of Incorp. TX
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,119,22424,013,06341,302,67255,196,08570,725,44719,229,232
Cash and cash equivalent4,422,8387,511,07921,937,74937,201,78651,524,29519,229,232
Short-term investments5,696,38616,501,98419,364,92317,994,29919,201,152 
Restricted cash and investments    541,180  
Prepaid expense294,000318,000308,000504,000  
Deferred costs88,000    101,205
Other undisclosed current assets301,948916,5661,730,6532,481,4721,990,953906,485
Total current assets:10,803,17225,247,62943,341,32558,722,73772,716,40020,236,922
Noncurrent Assets
Operating lease, right-of-use asset75,595239,985228,29547,687185,943 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization31,87547,44052,12748,00830,24521,507
Deposits noncurrent assets      101,205
Restricted cash and investments     1,000,000 
Deferred costs88,431     
Other noncurrent assets36,73836,73825,86917,88917,889 
Total noncurrent assets:232,639324,163306,291113,5841,234,077122,712
TOTAL ASSETS:11,035,81125,571,79243,647,61658,836,32173,950,47720,359,634
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,423,0484,140,3612,505,2112,745,4072,174,109 
Other undisclosed accounts payable and accrued liabilities4,423,0484,140,3612,505,2112,745,4072,174,109 
Other undisclosed current liabilities78,539190,814172,97552,890152,058552,339
Total current liabilities:4,501,5874,331,1752,678,1862,798,2972,326,167552,339
Noncurrent Liabilities
Long-term debt and lease obligation:     52,890 
Liabilities, other than long-term debt  52,84361,496   
Operating lease, liability  52,84361,496 52,890 
Other undisclosed noncurrent liabilities     (52,890)108,500
Total noncurrent liabilities:  52,84361,496 52,890108,500
Total liabilities:4,501,5874,384,0182,739,6822,798,2972,379,057660,839
Equity
Equity, attributable to parent6,534,22421,187,77440,907,93456,038,02471,571,42019,698,795
Common stock1,1251,0781,0721,0861,109622
Additional paid in capital99,652,72497,058,32396,258,72695,691,19496,685,92432,358,068
Accumulated other comprehensive income (loss)25,430153,990(107,460)(371,386)(92,689) 
Accumulated deficit(93,145,055)(76,025,617)(55,244,404)(39,282,870)(25,022,924)(12,659,895)
Total equity:6,534,22421,187,77440,907,93456,038,02471,571,42019,698,795
TOTAL LIABILITIES AND EQUITY:11,035,81125,571,79243,647,61658,836,32173,950,47720,359,634

Income Statement (P&L) (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues22,4089,065    
Gain (loss) on disposition of assets for financial service operations22,4089,065(115,840)(128,922)  
Cost of revenue
(Cost of Product and Service Sold)		(7,366,050)(11,400,000)    
Gross profit:(7,343,642)(11,390,935)    
Operating expenses(17,978,494)(22,216,437)(17,877,570)(14,432,753)(12,591,508)(5,908,190)
Other operating expense, net
(Other Expenses)		     (4,483,000) 
Other undisclosed operating income7,343,64211,390,935115,840128,922  
Operating loss:(17,978,494)(22,216,437)(17,877,570)(14,432,753)(17,074,508)(5,908,190)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))		421,125692,8691,150,648(31,548)160,550 
Interest and debt expense      
Loss from continuing operations:(17,557,369)(21,523,568)(16,726,922)(14,464,301)(16,913,958)(5,908,190)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(16,913,958)(5,908,190)
Other undisclosed net income     4,550,92911,816,190
Net income (loss):(17,557,369)(21,523,568)(16,726,922)(14,464,301)(12,363,029)5,908,000
Net loss attributable to noncontrolling interest     (12,363,000) 
Other undisclosed net income (loss) attributable to parent437,931742,355765,388204,35512,363,000(11,816,190)
Net loss attributable to parent:(17,119,438)(20,781,213)(15,961,534)(14,259,946)(12,363,029)(5,908,190)
Preferred stock dividends and other adjustments     (961,545)(1,192,241)
Other undisclosed net income available to common stockholders, basic     961,545 
Net loss available to common stockholders, diluted:(17,119,438)(20,781,213)(15,961,534)(14,259,946)(12,363,029)(7,100,431)

Comprehensive Income (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(17,557,369)(21,523,568)(16,726,922)(14,464,301)(12,363,029)5,908,000
Other comprehensive income (loss)(128,560)261,450263,926(278,697)  
Comprehensive income (loss):(17,685,929)(21,262,118)(16,462,996)(14,742,998)(12,363,029)5,908,000
Comprehensive loss, net of tax, attributable to noncontrolling interest     (12,363,000) 
Other undisclosed comprehensive income, net of tax, attributable to parent437,931742,355765,388204,355  
Comprehensive income (loss), net of tax, attributable to parent:(17,247,998)(20,519,763)(15,697,608)(14,538,643)(24,726,029)5,908,000

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: